Latest News

  • BSGM response to Guardian article

    BSGM response to Guardian article

    posted on 20th July 2017  |  0 Comments  |  Not tagged.

    Posted from: BSGM

    The BSGM has responded to the recent guardian article 'We are all mutants now" 

    Please see the comments section at the end of the article for the BSGM response.

  • Update for ACGS members

    Update for ACGS members

    posted on 14th July 2017  |  0 Comments  |  Not tagged.

    Posted from: ACGS

    Please click here to download the update

  • Fundamentals Registration Open

    Fundamentals Registration Open

    posted on 12th July 2017  |  0 Comments  |  Not tagged.

    Posted from: CGS

    The Fundamentals of Clinical Genomics Course, 2018 is now open for registration.

    Although the registration deadline is 17th October 2017, the course has been very popular in previous years, and so early registration is recommended to ensure a place.

    Further details can be found on the events page

  • BSGM response to CMO report

    posted on 10th July 2017  |  0 Comments  |  Not tagged.

    Posted from: BSGM

    The British Society of Genetic Medicine represents over 1800 professionals, including doctors, genetic counselors and laboratory scientists, working in the NHS, providing diagnosis, treatment and support to individuals and families affected by genetic and genomic conditions. This includes a network of clinical laboratories providing hundreds of thousands of genetic and genomic test results to patients with rare diseases and cancer every year to diagnose or predict these conditions and inform the selection of the most effective treatments or preventions. New genomic technologies, that have revolutionized genomic approaches over the past decade, are already in routine use by these laboratories.

    We are delighted that the Chief Medical Officer, Dame Sally Davies, has recognized the power of Genomic Medicine to make a significant difference to the well being of patients and their families in her Annual Report. The Report builds on the foundations laid by the network of Regional Genetics Services across the UK over the past decades, which have established an international reputation for the quality of the services provided within the NHS. These services have also catalysed novel research discoveries through the close working relationships between NHS and university departments in genomics.

    In order to capitalize on the opportunities afforded by Genomic Medicine, these Regional Genetic Services are well placed to transform practices across all branches of medicine, including general practice, so that both the potential and the limitations of genetic/genomic testing are appropriately realised. Whole genome sequencing, at the cost and speeds available today, is a remarkable technical achievement, yet to make a diagnosis or accurate prediction it needs to be interpreted in the context of accurate clinical information. The expertise to link the clinical information with sequence data is central to the skills of our professional members.

    Natural history studies, clinical trials and support for both health care professional and public education are also essential to continue to deliver a world class clinical service in genomic medicine. Whilst some laboratory functions are ripe for centralization, the role of existing regional laboratories working with clinical experts remains vital for the interpretation of complex genomic data. We welcome the CMO report and are willing and ready to help deliver genomic medicine to all areas of medical practice to meet the needs of all NHS patients.

    Prof William Newman on behalf of the British Society for Genetic Medicine

    Please click here for a PDF version of the report


  • Cancer Gene Panel Testing Meeting

    Cancer Gene Panel Testing Meeting

    posted on 17th May 2017  |  0 Comments  |  Not tagged.

    Posted from: CGG

    On the 8th May 2017, the clinical cancer genetics leads across the UK met to agree the set of genes with good evidence for being associated with breast, ovarian, colorectal cancer and polyposis syndromes.

    An agreement was reached about which genes clinicians would approve being testing for in clinical diagnostic labs.



     This meeting will be followed up by:

    - Compilation of a gene dossier for UKGTN for breast, ovarian and colorectal cancer/polyposis panel testing

    - CGG-produced pragmatic management suggestions for all genes included to facilitate consistency across the UK, whilst acknowledging local constraints and protocols